Download
https://www.opindia.com/2021/07/bharat-biotech-phase-3-trials-covaxin-india-made-vaccine-high-efficacy/
Bharat Biotech releases Phase-3 trials data of Covaxin: Indian-made vaccine 77.8% effective against mild cases, 93% against severe cases
Share